Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Ondine Biomedical - Result of AGM and voting results | 1 | RNS | ||
Mi | Ondine Biomedical - Steriwave Standard of Care in 2nd Health Authority | - | RNS | ||
19.06. | Ondine Biomedical - Second Quebec Hospital Adopts Steriwave | - | RNS | ||
16.06. | Ondine Biomedical - UK Doctor Wins Award for NHS Steriwave Innovation | - | RNS | ||
12.06. | Ondine Biomedical - NHS Trust up for HSJ Award for Steriwave Use | - | RNS | ||
10.06. | Ondine Biomedical enthüllt Durchbruch bei der Verbesserung von Antibiotika | 5 | Investing.com Deutsch | ||
10.06. | Ondine Biomedical reveals breakthrough in antibiotic enhancement | 2 | Investing.com | ||
10.06. | Ondine Biomedical - Ondine Presents Groundbreaking Findings | - | RNS | ||
ONDINE BIOMEDICAL Aktie jetzt für 0€ handeln | |||||
10.06. | Ondine Biomedical - Exercise of Options | - | RNS | ||
09.06. | Ondine Biomedical - UCL Shows Steriwave Effective Against Mucor Fungus | - | RNS | ||
05.06. | Ondine Biomedical - Canada's Largest Cardiac Centre Adopts Steriwave | - | RNS | ||
04.06. | Ondine Biomedical - Notice of AGM | - | RNS | ||
15.05. | EARNINGS AND TRADING: Ondine widens loss as research expenses rise | 1 | Alliance News | ||
15.05. | Ondine Biomedical stock falls following financial results | 1 | Investing.com | ||
15.05. | Ondine Biomedical-Aktie fällt nach Finanzergebnissen | 1 | Investing.com Deutsch | ||
15.05. | Ondine Biomedical verzeichnet 70% Umsatzsteigerung in 2024 | 1 | Investing.com Deutsch | ||
15.05. | Ondine Biomedical reports 70% revenue surge in 2024 | 1 | Investing.com | ||
15.05. | Ondine Biomedical - 2024 Full Year Results and Annual Report | - | RNS | ||
12.05. | Ondine Biomedical schließt Partnerschaft mit CAN Health Network | 2 | Investing.com Deutsch | ||
12.05. | Ondine Biomedical partners with CAN Health Network | 1 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SOLID BIOSCIENCES | 4,720 | -1,87 % | Citi startet Berichterstattung für Solid Biosciences mit Kaufempfehlung | ||
HARMONY BIOSCIENCES | 31,980 | +0,38 % | Mizuho reaffirms Harmony Biosciences stock rating on positive orexin data | ||
CG ONCOLOGY | 25,950 | -0,46 % | CG Oncology Inc.: CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates | - Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M -- Promising early signal... ► Artikel lesen | |
QIAGEN | 41,000 | -0,56 % | Minimale Kursveränderung bei Qiagen NV-Aktie (40,55 €) | Am Aktienmarkt ist der Anteilsschein von Qiagen NV gegenwärtig unauffällig. Das Wertpapier kostete zuletzt 40,55 Euro. Der heutige Börsentag brachte bislang wenig Kursbewegung bei der Aktie von Qiagen... ► Artikel lesen | |
LYELL IMMUNOPHARMA | 8,940 | -1,97 % | Lyell Immunopharma, Inc. - 8-K, Current Report | ||
SPRINGWORKS THERAPEUTICS | 46,990 | 0,00 % | SpringWorks Therapeutics, Inc. - 8-K, Current Report | ||
KYMERA THERAPEUTICS | 44,080 | -3,57 % | Gilead Sciences Partners Kymera Therapeutics To Develop Novel Oral Molecular Glue CDK2 Degraders | FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) and Kymera Therapeutics, Inc. (KYMR) announced Wednesday that they have entered into an exclusive option and license agreement to accelerate... ► Artikel lesen | |
CLIMB BIO | 1,180 | -6,35 % | Climb Bio, Inc.: Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer | Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical Development, and Operations Expertise Company Also Hires Cindy J. Driscoll... ► Artikel lesen | |
ADMA BIOLOGICS | 18,160 | -1,30 % | Will Strong Asceniv Sales Drive ADMA Biologics Further? | ||
ALLOGENE THERAPEUTICS | 1,180 | -1,67 % | Allogene Therapeutics, Inc. - 8-K, Current Report | ||
RECURSION PHARMACEUTICALS | 5,030 | -6,85 % | Recursion Pharmaceuticals: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing... ► Artikel lesen | |
EVOTEC | 7,138 | -0,81 % | Aktienmarkt: Evotec-Aktie kann sich nicht behaupten (6,38 €) | An der deutschen Börse liegt das Wertpapier von Evotec aktuell im Minus. Das Wertpapier notiert zur Stunde bei 6,38 Euro. Am Aktienmarkt liegt die Aktie von Evotec gegenwärtig im Minus. Die Aktie verbilligte... ► Artikel lesen | |
BIONTECH | 90,70 | -0,60 % | Die nächste Cashcow? Schnelle Prozente mit NetraMark, Moderna, BioNTech | Erinnern Sie sich noch an den Impfstoff-Wettlauf in der Corona-Zeit? Damals bestimmte das Duell zwischen BioNTech und Curevac auch das Geschehen an der Börse. Anleger der ersten Stunde machten schnell... ► Artikel lesen | |
CARGO THERAPEUTICS | 4,190 | -0,71 % | Pre-market Movers: Leishen Energy, Black Diamond Therapeutics, FST Corp., 5E Advanced Materials, CARGO Therapeutics | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.00 A.M. ET).In the Green Leishen Energy Holding Co., Ltd. (LSE) is up over... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 20,610 | -3,33 % | H.C. Wainwright Sticks With Bullish Call on Summit Therapeutics, $44 Target |